Consolidation of manufacturing sites

RNS Number : 4280F
EKF Diagnostics Holdings PLC
12 November 2015
 

 

 

EKF Diagnostics Holdings plc
("EKF" or the "Company")

 

Consolidation of manufacturing sites

 

EKF Diagnostics Holdings plc (AIM: EKF), the AIM listed point-of-care, central laboratory and molecular diagnostics business, announces that it will close its manufacturing site in Sanford, Florida.

 

The site, which manufactures centrifuges and hematocrit analysers under the Separation Technology, Inc. brand, will close in Q1 2016 as part of EKF's announced intention to make further operational savings.

 

EKF will transfer production to its Boerne, Texas plant. The Company will seek to retain staff in key positions, where possible.

 

Julian Baines, CEO of EKF Diagnostics commented: "As we announced in our Interim Report in September the senior management team is committed to continuing the process of integrating the Group's manufacturing facilities. The closure of the Sanford site allows us to concentrate our production within one US site and benefit from the associated savings in operational costs."

 

 

EKF Diagnostics Holdings plc     

Tel: 029 2071 0570

Ron Zwanziger, Chairman

Tel: +1 339 221 6282

David Evans, Deputy Non-Executive Chairman

Mob: 07740 084 452

Julian Baines, CEO

Mob: 07788 420 859

Paul Foulger, CFO

Mob: 07710 989 255

 

 

Panmure Gordon (UK) Limited

Tel: 020 7886 2500

Robert Naylor (Corporate Finance)

 

Paul Fincham (Corporate Finance)

 

 

 

Walbrook PR Limited 

Tel: 020 7933 8780 or ekf@walbrookpr.com

Paul McManus

Mob: 07980 541 893

Lianne Cawthorne

Mob: 07584 391 303

       

 

 

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBIBDBGXBBGUB
UK 100

Latest directors dealings